These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32054829)

  • 1. Dysregulation of the miR-148a-GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma.
    Tiemin P; Peng X; Qingfu L; Yan W; Junlin X; Zhefeng H; Ming Z; Desen L; Qinghui M
    Oncogenesis; 2020 Feb; 9(2):19. PubMed ID: 32054829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
    Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
    J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs.
    Yang R; Wang D; Han S; Gu Y; Li Z; Deng L; Yin A; Gao Y; Li X; Yu Y; Wang X
    Int J Biol Sci; 2022; 18(1):43-64. PubMed ID: 34975317
    [No Abstract]   [Full Text] [Related]  

  • 4. miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma.
    Lixin S; Wei S; Haibin S; Qingfu L; Tiemin P
    Mol Carcinog; 2020 Dec; 59(12):1371-1381. PubMed ID: 33052627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
    Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
    Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down regulation of miR-148a is related to enhanced pancreatic cancer pathogenesis through targeting GLUT1.
    Wu L; Qiu W; Sun J
    Int J Clin Exp Pathol; 2018; 11(10):4950-4956. PubMed ID: 31949571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUOX and GLUT1 are biomarkers for the prognosis in large duct type intrahepatic cholangiocarcinoma.
    Kinjo Y; Naito Y; Akiba J; Sadashima E; Nakayama M; Tanigawa M; Hisaka T; Okabe Y; Yano H
    Hum Pathol; 2022 Oct; 128():11-19. PubMed ID: 35764144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma.
    Cigliano A; Pilo MG; Mela M; Ribback S; Dombrowski F; Pes GM; Cossu A; Evert M; Calvisi DF; Utpatel K
    Medicina (Kaunas); 2019 Dec; 56(1):. PubMed ID: 31861475
    [No Abstract]   [Full Text] [Related]  

  • 10. SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis.
    Chen F; Aye L; Yu L; Liu L; Liu Y; Lin Y; Gao D; Gao Q; Zhang S
    Carcinogenesis; 2023 May; 44(3):232-241. PubMed ID: 36857607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR-148a-3p/ROCK1 axes.
    Pan L; Meng Q; Li H; Liang K; Li B
    Biomed Pharmacother; 2019 Dec; 120():109423. PubMed ID: 31550677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition.
    Yang LX; Gao Q; Shi JY; Wang ZC; Zhang Y; Gao PT; Wang XY; Shi YH; Ke AW; Shi GM; Cai JB; Liu WR; Duan M; Zhao YJ; Ji Y; Gao DM; Zhu K; Zhou J; Qiu SJ; Cao Y; Tang QQ; Fan J
    Hepatology; 2015 Dec; 62(6):1804-16. PubMed ID: 26340507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
    Di Matteo S; Nevi L; Costantini D; Overi D; Carpino G; Safarikia S; Giulitti F; Napoletano C; Manzi E; De Rose AM; Melandro F; Bragazzi M; Berloco PB; Giuliante F; Grazi G; Giorgi A; Cardinale V; Adorini L; Gaudio E; Alvaro D
    PLoS One; 2019; 14(1):e0210077. PubMed ID: 30677052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-148a inhibits viability and invasion of ovarian cancer OVCAR3 cells by targeting FOXO3.
    Zhu D; Yuan D; Guo R; Zhang L; Guo T; Zhao Y; Wang J; Chen X; Qian H; Ge H
    Oncol Lett; 2019 Jul; 18(1):402-410. PubMed ID: 31289511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143.
    Dong P; Wang F; Taheri M; Xiong Y; Ihira K; Kobayashi N; Konno Y; Yue J; Watari H
    Front Oncol; 2022; 12():912935. PubMed ID: 35712514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
    Mancarella S; Serino G; Gigante I; Cigliano A; Ribback S; Sanese P; Grossi V; Simone C; Armentano R; Evert M; Calvisi DF; Giannelli G
    J Exp Clin Cancer Res; 2022 Feb; 41(1):65. PubMed ID: 35172861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma.
    Li Z; Zhou H; Xia Z; Xia T; Du G; Franziska SD; Li X; Zhai X; Jin B
    Biomark Res; 2023 Mar; 11(1):33. PubMed ID: 36978140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance.
    Yuan X; Li J; Coulouarn C; Lin T; Sulpice L; Bergeat D; De La Torre C; Liebe R; Gretz N; Ebert MPA; Dooley S; Weng HL
    Br J Cancer; 2018 Nov; 119(11):1358-1366. PubMed ID: 30420613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HOXA11-AS promotes migration and invasion through modulating miR-148a/WNT1/β-catenin pathway in gastric cancer.
    Guo T; Yuan X; Liu DF; Peng SH; Xu AM
    Neoplasma; 2020 May; 67(3):492-500. PubMed ID: 32009419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.